Usually, a high level of tumor-infiltrated CD8 + T-cells indicates a good prognosis, which is also a key factor in immune checkpoint blockade (ICB) therapy (Gubin et al. 2014; Sade-Feldman et al. 2019). The gene discussed is CD8A; the disease is neoplasm.